Skip to Main content Skip to Navigation
Journal articles

Methadone in primary care in France: Using evidence for action against hepatitis C

P. Roux 1 A. Morel 2 D. Wolfe 3 Patrizia Carrieri 1
1 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale
2 Association de prévention et de soin en addictologie - Oppelia [Paris]
3 OSI - Open Society Foundations
Abstract : In France, two opioid substitution treatments have been available since the mid-1990s: buprenorphine through primary care and specialized clinics, and methadone only through specialized clinics.
Keywords : Methadone Hepatitis C Primary care Advocacy Scientific evidence
Document type :
Journal articles
Complete list of metadata
https://hal-amu.archives-ouvertes.fr/hal-02613452
Contributor : Administrateur Hal Amu <>
Submitted on : Wednesday, May 20, 2020 - 10:35:01 AM
Last modification on : Tuesday, June 2, 2020 - 6:58:03 PM

Links full text

openaccess

Identifiers

Collections

UNIV-AMU | U1252 | INSERM

Citation

P. Roux, A. Morel, D. Wolfe, Patrizia Carrieri. Methadone in primary care in France: Using evidence for action against hepatitis C. International Journal of Drug Policy, Elsevier, 2019, 71, pp.91-92. ⟨10.1016/j.drugpo.2019.06.013⟩. ⟨hal-02613452⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

38